Parallax Health Sciences Inc. (fka PRLX)

[DaReal]

OTCMarket got updated: ~4M Float!

Parallax Health Sciences Inc.. ("Parallax") is a bio-medical company which owns a line of Point of Care diagnostic tests on a single platform. Parallax is developing a novel handheld diagnostic testing system that is simple, rapid and elegant, offering the potential to transform the diagnostic landscape by transitioning critical tests from the centralized lab directly to the hands of the physician or clinicians. Paraallax has an exclusive license for a number of previously FDA approved tests. Parallax also has pending patents in an effort to protect its underlying technology as well as a pending patent for methods for future test development. Parallax has rights to previously FDA 510k Cleared tests for certain Infectious Diseases and a FDA 510k Cleared Desk Top Analyzer. A mobile hand held device is being developed based on the technology utilized in the desktop analyzer.

PRLX Security Details
Share Structure
Market Value1 $20,256,190 a/o Feb 03, 2014
Shares Outstanding 126,601,186 a/o Jan 29, 2014
Float 4,227,329 a/o Jan 29, 2014
Authorized Shares 250,000,000 a/o Mar 08, 2011
Par Value 0.0001